India

Moderna gets emergency use authorisation for its COVID-19 vaccine in US

Moderna has become the second company to get emergency use authorisation for its anti-coronavirus vaccine from FDA, a week after the one developed by Pfizer received a similar approval

Moderna has become the second company to get emergency use authorisation for its anti-coronavirus vaccine from the US Food and Drug Administration (FDA), a week after the one developed by Pfizer received a similar approval.

According to an official statement, the FDA has determined that the Moderna COVID-19 vaccine has met the statutory criteria for issuance of an emergency use authorisation (EUA).

Published: undefined

"Congratulations, the Moderna vaccine is now available!" President Donald Trump tweeted soon after.

The FDA based its recommendation on the totality of scientific evidence shared by Moderna, including a data analysis from the pivotal phase three clinical study announced on November 30. The primary efficacy analysis conducted on 196 cases indicated a vaccine efficacy rate of 94.1 per cent.

This vaccine is for people aged 18 or older.

Published: undefined

Follow us on: Facebook, Twitter, Google News, Instagram 

Join our official telegram channel (@nationalherald) and stay updated with the latest headlines

Published: undefined